慢性炎性脱髓鞘性多发性神经根神经病

Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force - second revision. Eur J Neurol. 2021 Nov;28(11):3556-83.全文  摘要

Dyck PJB, Tracy JA. History, diagnosis, and management of chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clin Proc. 2018 Jun;93(6):777-93.全文  摘要

Broers MC, Bunschoten C, Drenthen J, et al. Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2021 Jun;28(6):2065-73.全文  摘要

Oaklander AL, Lunn MP, Hughes RA, et al. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev. 2017 Jan 13;(1):CD010369.全文  摘要

Mahdi-Rogers M, Brassington R, Gunn AA, et al. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2017 May 8;(5):CD003280.全文  摘要

1. Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force - second revision. Eur J Neurol. 2021 Nov;28(11):3556-83.全文  摘要

2. Bunschoten C, Jacobs BC, Van den Bergh PYK, et al. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019 Aug;18(8):784-94. 摘要

3. Dyck PJB, Tracy JA. History, diagnosis, and management of chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clin Proc. 2018 Jun;93(6):777-93.全文  摘要

4. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical and electrophysiological study of 92 cases. Brain. 1987 Dec;110 (Pt 6):1617-30. 摘要

5. Hattori N, Misu K, Koike H, et al. Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 2001 Feb 15;184(1):57-63. 摘要

6. Said G. Chronic inflammatory demyelinative polyneuropathy. J Neurol. 2002 Mar;249(3):245-53. 摘要

7. Oh SJ, Kurokawa K, de Almeida DF, et al. Subacute inflammatory demyelinating neuropathy. Neurology. 2003 Dec 9;61(11):1507-12. 摘要

8. Nevo Y, Pestronk A, Kornberg AJ, et al. Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up. Neurology. 1996 Jul;47(1):98-102. 摘要

9. Simmons Z, Wald JJ, Albers JW. Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults. Muscle Nerve. 1997 Aug;20(8):1008-15. 摘要

10. Mygland A, Monstad P. Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness. Arch Neurol. 2003 Feb;60(2):260-4.全文  摘要

11. Steck AJ. Anti-MAG neuropathy: from biology to clinical management. J Neuroimmunol. 2021 Dec 15;361:577725.全文  摘要

12. Lewis RA, Sumner AJ, Brown MJ, et al. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982 Sep;32(9):958-64. 摘要

13. Saperstein DS, Amato AA, Wolfe GI, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve. 1999 May;22(5):560-6. 摘要

14. Thomas PK, Claus D, Jaspert A, et al. Focal upper limb demyelinating polyneuropathy. Brain. 1996 Jun;119 (Pt 3):765-74.全文  摘要

15. Broers MC, Bunschoten C, Nieboer D, et al. Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Neuroepidemiology. 2019;52(3-4):161-72.全文  摘要

16. Broers MC, Bunschoten C, Drenthen J, et al. Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2021 Jun;28(6):2065-73.全文  摘要

17. Rajabally YA, Peric S, Bozovic I, et al. Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy: a European collaborative study. Muscle Nerve. 2021 Dec;64(6):657-61. 摘要

18. Bril V, Blanchette CM, Noone JM, et al. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy. J Diabetes Complications. 2016 Sep-Oct;30(7):1401-7.全文  摘要

19. Chen Y, Tang X. Chronic inflammatory demyelinating polyradiculoneuropathy in association with concomitant diseases: identification and management. Front Immunol. 2022 Jul 4;13:890142.全文  摘要

20. Doneddu PE, Cocito D, Manganelli F, et al; Italian CIDP Database study group. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy. J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1092-9.全文  摘要

21. Krendel DA, Parks HP, Anthony DC, et al. Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1989 Apr;12(4):257-64. 摘要

22. Schmidt B, Toyka KV, Kiefer R, et al. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve. 1996 Apr;19(4):474-87. 摘要

23. Rajabally YA, Nicolas G, Piéret F, et al. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1364-8. 摘要

24. Magda P, Latov N, Brannagan TH, et al. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol. 2003 Dec;60(12):1755-9.全文  摘要

25. Koski CL, Baumgarten M, Magder LS, et al. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 2009 Feb 15;277(1-2):1-8. 摘要

26. Cocito D, Chio A, Tavella A, et al. Treatment response and electrophysiological criteria in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol. 2006 Jun;13(6):669-70. 摘要

27. Thaisetthawatkul P, Logigian EL, Herrmann DH. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology. 2002 Nov 26;59(10):1526-32. 摘要

28. Rajabally YA, Jacob S. Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol. 2006 Sep;117(9):2079-84. 摘要

29. Rajabally YA, Jacob S, Hbahbih M. Optimizing the use of electrophysiology in the diagnosis of chronic inflammatory demyelinating polyneuropathy: a study of 20 cases. J Peripher Nerv Syst. 2005 Sep;10(3):282-92. 摘要

30. Abraham A, Alabdali M, Qrimli M, et al. Treatment responsiveness in CIDP patients with diabetes Is associated with higher degrees of demyelination. PLoS One. 2015 Oct 13;10(10):e0139674.全文  摘要

31. Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol. 2010 Mar;17(3):356-63.全文  摘要

32. London Z, Albers JW. Toxic neuropathies associated with pharmaceutic and industrial agents. Neurol Clin. 2007 Feb;25(1):257-76. 摘要

33. Herskovitz S, Schaumberg HH. Neuropathy caused by drugs. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. Philadelphia, PA: Elsevier Saunders; 2005:2553-83.

34. Pareyson D. Differential diagnosis of Charcot-Marie-Tooth disease and related neuropathies. Neurol Sci. 2004 Jun;25(2):72-82. 摘要

35. Thomas PK, Goebel HH. Lysosomal and peroxisomal disorders. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. Philadelphia, PA: Elsevier Saunders; 2005:1845-82.

36. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States. ​Jun 2022 [internet publication].全文

37. Michaelides A, Hadden RDM, Sarrigiannis PG, et al. Pain in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Pain Ther. 2019 Dec;8(2):177-85.全文  摘要

38. Oh SJ, Joy JL, Kuruoglu R. Chronic sensory demyelinating neuropathy: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):677-80.全文  摘要

39. Ayrignac X, Viala K, Koutlidis RM, et al. Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity? Muscle Nerve. 2013 Nov;48(5):727-32. 摘要

40. Barohn RJ, Kissel JT, Warmolts JR, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol. 1989 Aug;46(8):878-84. 摘要

41. Cornblath DR, Asbury AK, Albers JW, et al. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP): report from the Ad Hoc Subcommittee of the AAN AIDS Task Force. Neurology. 1991 May;41(5):617-8. 摘要

42. Kaplan A, Brannagan TH 3rd. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2017 Apr;55(4):476-82. 摘要

43. Liberatore G, Manganelli F, Cocito D, et al; Italian CIDP Database Study Group. Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: data from the Italian CIDP Database. J Peripher Nerv Syst. 2020 Jun;25(2):152-61.全文  摘要

44. Breiner A, Bourque PR, Allen JA. Updated cerebrospinal fluid total protein reference values improve chronic inflammatory demyelinating polyneuropathy diagnosis. Muscle Nerve. 2019 Aug;60(2):180-3. 摘要

45. Massie R, Mauermann ML, Staff NP, et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain. 2012 Oct;135(pt 10):3074-88.全文  摘要

46. Cornblath DR, McArthur JC, Kennedy PG, et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987 Jan;21(1):32-40. 摘要

47. Simpson DM, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin. 1992 Aug;10(3):685-711. 摘要

48. Illes Z, Blaabjerg M. Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies. Handb Clin Neurol. 2018;146:125-38. 摘要

49. Taniguchi N, Itoh K, Wang Y, et al. Sonographic detection of diffuse peripheral nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Ultrasound. 2000 Nov-Dec;28(9):488-91. 摘要

50. Kerasnoudis A, Pitarokoili K, Behrendt V, et al. Correlation of nerve ultrasound, electrophysiological and clinical findings in chronic inflammatory demyelinating polyneuropathy. J Neuroimaging. 2015 Mar-Apr;25(2):207-16. 摘要

51. Zaidman CM, Harms MB, Pestronk A. Ultrasound of inherited vs. acquired demyelinating polyneuropathies. J Neurol. 2013 Dec;260(12):3115-21.全文  摘要

52. Sugimoto T, Ochi K, Hosomi N, et al. Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy. J Neurol. 2013 Oct;260(10):2580-7. 摘要

53. Di Pasquale A, Morino S, Loreti S, et al. Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity. Neurology. 2015 Feb 24;84(8):803-9. 摘要

54. Grimm A, Vittore D, Schubert V, et al. Ultrasound aspects in therapy-naive CIDP compared to long-term treated CIDP. J Neurol. 2016 Jun;263(6):1074-82. 摘要

55. Herraets IJT, Goedee HS, Telleman JA, et al. Nerve ultrasound for diagnosing chronic inflammatory neuropathy: a multicenter validation study. Neurology. 2020 Sep 22;95(12):e1745-53. 摘要

56. Zaidman CM, Pestronk A. Nerve size in CIDP varies with disease activity and therapy response over time: a retrospective ultrasound study. Muscle Nerve. 2014 Nov;50(5):733-8.全文  摘要

57. Duggins AJ, McLeod JG, Pollard JD, et al. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain. 1999 Jul;122 (Pt 7):1383-90.全文  摘要

58. Bus SRM, Broers MC, Lucke IM, et al. Clinical outcome of CIDP one year after start of treatment: a prospective cohort study. J Neurol. 2022 Feb;269(2):945-55.全文  摘要

59. Merkies ISJ, van Schaik IN, Léger JM, et al; PRIMA Trial Investigators and the PATH Study Group. Efficacy and safety of IVIG in CIDP: combined data of the PRIMA and PATH studies. J Peripher Nerv Syst. 2019 Mar;24(1):48-55.全文  摘要

60. van Lieverloo GGA, Peric S, Doneddu PE, et al. Corticosteroids in chronic inflammatory demyelinating polyneuropathy: a retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone. J Neurol. 2018 Sep;265(9):2052-9.全文  摘要

61. Ikeda S, Koike H, Nishi R, et al. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):988-96. 摘要

62. Menon D, Katzberg HD, Bril V. Treatment approaches for atypical CIDP. Front Neurol. 2021 Mar 15;12:653734.全文  摘要

63. Vural A, Doppler K, Meinl E. Autoantibodies against the node of Ranvier in seropositive chronic inflammatory demyelinating polyneuropathy: diagnostic, pathogenic, and therapeutic relevance. Front Immunol. 2018 May 14;9:1029.全文  摘要

64. Godil J, Barrett MJ, Ensrud E, et al. Refractory CIDP: clinical characteristics, antibodies and response to alternative treatment. J Neurol Sci. 2020 Nov 15;418:117098. 摘要

65. Delmont E, Manso C, Querol L, et al. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy. Brain. 2017 Jul 1;140(7):1851-8. 摘要

66. Querol L, Rojas-García R, Diaz-Manera J, et al. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins. Neurol Neuroimmunol Neuroinflamm. 2015 Sep 3;2(5):e149.全文  摘要

67. Gorson KC, Ropper AH, Weinberg DH. Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 1999 Jun;22(6):758-65. 摘要

68. Kimura A, Sakurai T, Koumura A, et al. Motor-dominant chronic inflammatory demyelinating polyneuropathy. J Neurol. 2010 Apr;257(4):621-9. 摘要

69. Pegat A, Boisseau W, Maisonobe T, et al. Motor chronic inflammatory demyelinating polyneuropathy (CIDP) in 17 patients: clinical characteristics, electrophysiological study, and response to treatment. J Peripher Nerv Syst. 2020 Jun;25(2):162-70. 摘要

70. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology. 1997 Feb;48(2):321-8. 摘要

71. Bouchard C, Lacroix C, Plante V, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology. 1999 Feb;52(3):498-503. 摘要

72. Henderson RD, Sandroni P, Wijdicks EF. Chronic inflammatory demyelinating polyneuropathy and respiratory failure. J Neurol. 2005 Oct;252(10):1235-7. 摘要

73. Stamboulis E, Katsaros N, Koutsis G, et al. Clinical and subclinical autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2006 Jan;33(1):78-84.全文  摘要

74. Lyu RK, Tang LM, Wu YR, et al. Cardiovascular autonomic function and sympathetic skin response in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2002 Nov;26(5):669-72. 摘要

75. Thomas PK, Walker RW, Rudge P, et al. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain. 1987 Feb;110 (Pt 1):53-76. 摘要

76. Mendell JR, Kolkin S, Kissel JT, et al. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 1987 Aug;37(8):1291-4. 摘要

77. Falcone M, Scalise A, Minisci C, et al. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. Neurol Sci. 2006 Apr;27(1):58-62. 摘要

78. Jang JH, Cho CS, Yang KS, et al. Pattern analysis of nerve enlargement using ultrasonography in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol. 2014 Sep;125(9):1893-9. 摘要

79. Midroni G, de Tilly LN, Gray B, et al. MRI of the cauda equina in CIDP: clinical correlations. J Neurol Sci. 1999 Nov 15;170(1):36-44. 摘要

80. Kuwabara S, Nakajima M, Matsuda S, et al. Magnetic resonance imaging at the demyelinative foci in chronic inflammatory demyelinating polyneuropathy. Neurology. 1997 Apr;48(4):874-7. 摘要

81. Dionne A, Nicolle MW, Hahn AF. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve. 2010 Feb;41(2):202-7. 摘要

82. Ruts L, Drenthen J, Jacobs BC, et al. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology. 2010 May 25;74(21):1680-6. 摘要

83. Albers JW, Kelly JJ Jr. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989 Jun;12(6):435-51.全文  摘要

84. Kerasnoudis A, Pitarokoili K, Behrendt V, et al. Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy. Muscle Nerve. 2015 Jun;51(6):846-52. 摘要

85. Van den Bergh PY, Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2004 Apr;29(4):565-74. 摘要

86. Review article "Spotlight on ultrasonography in the diagnosis of peripheral nerve disease: the evidence to date"​. Int J Gen Med. 2021 Aug 16;14:4579-604.全文  摘要

87. Lewis RA, Sumner AJ. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology. 1982 Jun;32(6):592-6. 摘要

88. Attarian S, Azulay JP, Boucraut J, et al. Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies. Clin Neurophysiol. 2001 Mar;112(3):457-63. 摘要

89. Stanton M, Pannoni V, Lewis RA, et al. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2006 Oct;34(4):417-22. 摘要

90. Sander S, Ouvrier RA, McLeod JG, et al. Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):483-8.全文  摘要

91. Svahn J, Petiot P, Antoine JC, et al; Francophone anti-MAG Cohort Group. Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features. J Neurol Neurosurg Psychiatry. 2018 May;89(5):499-505. 摘要

92. Gondim FA, De Sousa EA, Latov N, et al. Anti-MAG/SGPG associated neuropathy does not commonly cause distal nerve temporal dispersion. J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):902-4.全文  摘要

93. Capasso M, Torrieri F, Di Muzio A, et al. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? Clin Neurophysiol. 2002 Mar;113(3):346-53. 摘要

94. Lunn MP, Nobile-Orazio E. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev. 2016 Oct 4;(10):CD002827.全文  摘要

95. Dalakas MC. Rituximab in anti-MAG neuropathy: more evidence for efficacy and more predictive factors. J Neurol Sci. 2017 Jun 15;377:224-6. 摘要

96. Dyck PJ, Low PA, Windebank AJ, et al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med. 1991 Nov 21;325(21):1482-6.全文  摘要

97. Kyle RA, Therneau TM, Rajkumar SV, et al. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc. 2004 Jul;79(7):859-66. 摘要

98. Nobile-Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve. 2005 Jun;31(6):663-80. 摘要

99. Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol. 1988 Jul;24(1):73-8. 摘要

100. van Schaik IN, Bossuyt PM, Brand A, et al. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis. Neurology. 1995 Aug;45(8):1570-7. 摘要

101. Merola A, Rosso M, Romagnolo A, et al. Peripheral nerve ultrasonography in chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: correlations with clinical and neurophysiological data. Neurol Res Int. 2016 May 29;2016:9478593.全文  摘要

102. Hou X, Liang Y, Cui P, et al. The clinical features of combined central and peripheral demyelination and antibodies against the node of Ranvier. Mult Scler. 2022 Mar;28(3):453-62. 摘要

103. Kira JI. Anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy/combined central and peripheral demyelination: strategies for diagnosis and treatment based on the disease mechanism. Front Neurol. 2021 Jun 10;12:665136.全文  摘要

104. Burnor E, Yang L, Zhou H, et al. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies. Neurology. 2018 Jan 2;90(1):e31-8.全文  摘要

105. Sinnreich M, Klein CJ, Daube JR, et al. Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology. 2004 Nov 9;63(9):1662-9. 摘要

106. Shelly S, Shouman K, Paul P, et al. Expanding the spectrum of chronic immune sensory polyradiculopathy: CISP-plus. Neurology. 2021 Apr 20;96(16):e2078-89.全文  摘要

107. Dispenzieri A, Suarez GA, Kyke RA. POEMS syndrome (osteosclerotic myeloma). In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. Philadelphia, PA: Elsevier Saunders; 2005:2453-69.

108. Kyle RA, Dyck PJ. Neuropathy associated with the monoclonal gammopathies. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. Philadelphia, PA: Elsevier Saunders; 2005:2255-76.

109. Bosch EP, Habermann TM, Tefferi A. Peripheral neuropathy with lymphoma, leukemia, and myeloproliferative disorders. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. Philadelphia, PA: Elsevier Saunders; 2005:2489-503.

110. Dörner M, Ceanga M, Schreiber F, et al. High-resolution nerve ultrasound abnormalities in POEMS syndrome - a comparative study. Diagnostics (Basel). 2021 Feb 9;11(2):264.全文  摘要

111. Cui RT, Huang XS, Liu JX, et al. Electrophysiological characteristics of polyneuropathy in POEMS syndrome: comparison with CIDP. J Clin Neurophysiol. 2012 Aug;29(4):345-8. 摘要

112. Nasu S, Misawa S, Sekiguchi Y, et al. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2012 May;83(5):476-9. 摘要

113. Mauermann ML, Sorenson EJ, Dispenzieri A, et al. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. J Neurol Neurosurg Psychiatry. 2012 May;83(5):480-6. 摘要

114. Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve. 2002 Apr;25(4):477-91. 摘要

115. Wannarong T, Katirji B. Painless diabetic lumbosacral radiculoplexus neuropathy: a manifestation of treatment-induced neuropathy of diabetes. J Clin Neuromuscul Dis. 2020 Dec;22(2):121-2. 摘要

116. Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2015 Jan;138(pt 1):43-52.全文  摘要

117. Haq RU, Pendlebury WW, Fries TJ, et al. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle Nerve. 2003 Apr;27(4):465-70. 摘要

118. Gorson KC, Ropper AH, Adelman LS, et al. Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2000 Jan;23(1):37-43. 摘要

119. Fukami Y, Koike H, Iijima M, et al. Role of complement components in vasculitic neuropathy associated with systemic lupus erythematosus and rheumatoid arthritis. Muscle Nerve. 2022 Aug;66(2):175-82. 摘要

120. Gorson KC. Vasculitic neuropathies: an update. Neurologist. 2007 Jan;13(1):12-9. 摘要

121. Collins MP, Dyck PJ, Gronseth GS, et al. Peripheral Nerve Society guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst. 2010 Sep;15(3):176-84. 摘要

122. Bedlack RS, Vu T, Hammans S, et al. MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2004 Mar;29(3):364-8. 摘要

123. Zuniga G, Ropper AH, Frank J. Sarcoid peripheral neuropathy. Neurology. 1991 Oct;41(10):1558-61. 摘要

124. Tavee J. Peripheral neuropathy in sarcoidosis. J Neuroimmunol. 2022 Jul 15;368:577864. 摘要

125. Lamotte G, Sandroni P. Updates on the diagnosis and treatment of peripheral autonomic neuropathies. Curr Neurol Neurosci Rep. 2022 Dec;22(12):823-37.全文  摘要

126. Gutierrez A, Turkewitz LJ, Correa H, et al. Primary systemic amyloidosis presenting with demyelinating features. Neurol Neurophysiol Neurosci. 2006 Dec 15:6. 摘要

127. Briemberg HR, Amato AA. Transthyretin amyloidosis presenting with multifocal demyelinating mononeuropathies. Muscle Nerve. 2004 Feb;29(2):318-22. 摘要

128. Mathis S, Magy L, Diallo L, et al. Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2012 Jan;45(1):26-31. 摘要

129. French CIDP Study Group. Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):115-8. 摘要

130. Muley SA, Parry GJ. Inflammatory demyelinating neuropathies. Curr Treat Options Neurol. 2009 May;11(3):221-7. 摘要

131. Elovaara I, Apostolski S, van Doorn P, et al; EFNS. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol. 2008 Sep;15(9):893-908.全文  摘要

132. Eftimov F, Winer JB, Vermeulen M, et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2013 Dec 30;(12):CD001797.全文  摘要

133. Mehndiratta, MM, Hughes, RA, Pritchard, J. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2015 Aug 25;(8):CD003906.全文  摘要

134. Hughes RA, Mehndiratta MM, Rajabally YA. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2017 Nov 29;(11):CD002062.全文  摘要

135. Oaklander AL, Lunn MP, Hughes RA, et al. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev. 2017 Jan 13;(1):CD010369.全文  摘要

136. van Schaik IN, Eftimov F, van Doorn PA, et al. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol. 2010 Mar;9(3):245-53. 摘要

137. Nobile-Orazio E, Pujol S, Kasiborski F, et al. An international multicenter efficacy and safety study of IqYmune in initial and maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy: PRISM study. J Peripher Nerv Syst. 2020 Dec;25(4):356-65.全文  摘要

138. Kuitwaard K, van den Berg LH, Vermeulen M, et al. Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1374-9. 摘要

139. McMillan HJ, Kang PB, Jones HR, et al. Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series. Neuromuscul Disord. 2013 Feb;23(2):103-11. 摘要

140. Kuitwaard K, Hahn AF, Vermeulen M, et al. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1331-6. 摘要

141. Mahdi-Rogers M, Brassington R, Gunn AA, et al. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2017 May 8;(5):CD003280.全文  摘要

142. Cocito D, Grimaldi S, Paolasso I, et al. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis. Eur J Neurol. 2011 Dec;18(12):1417-21. 摘要

143. Xiang Q, Cao Y, Song Z, et al. Cyclophosphamide for treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Clin Ther. 2022 Aug;44(8):1058-70. 摘要

144. Muley SA, Jacobsen B, Parry G, et al. Rituximab in refractory chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2020 May;61(5):575-9. 摘要

145. Kilidireas C, Anagnostopoulos A, Karandreas N, et al. Rituximab therapy in monoclonal IgM-related neuropathies. Leuk Lymphoma. 2006 May;47(5):859-64. 摘要

146. Gorson KC, Natarajan N, Ropper AH, et al. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve. 2007 Jan;35(1):66-9.全文  摘要

147. Benedetti L, Briani C, Franciotta D, et al. Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature. J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):306-8. 摘要

148. Dyck PJ, O'Brien P, Swanson C, et al. Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy. Neurology. 1985 Aug;35(8):1173-6. 摘要

149. Radziwill AJ, Schweikert K, Kuntzer T, et al. Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: an open-label study. Eur Neurol. 2006;56(1):37-8. 摘要

150. Bedi G, Brown A, Tong T, et al. Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy. J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):634-6. 摘要

151. van Schaik IN, Bril V, van Geloven N, et al. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2018 Jan;17(1):35-46. 摘要

152. van Schaik IN, Mielke O, Bril V, et al; PATH study group. Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study. Neurol Neuroimmunol Neuroinflamm. 2019 Sep;6(5):e590.全文  摘要

153. Karam C. Chronic inflammatory demyelinating polyradiculoneuropathy: five new things. Neurol Clin Pract. 2022 Jun;12(3):258-62. 摘要

154. Burt RK, Balabanov R, Tavee J, et al. Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol. 2020 Nov;267(11):3378-91. 摘要

155. Mahdi-Rogers M, Kazmi M, Ferner R, et al. Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy. J Peripher Nerv Syst. 2009 Jun;14(2):118-24. 摘要

156. Remenyi P, Masszi T, Borbenyi Z, et al. CIDP cured by allogeneic hematopoietic stem cell transplantation. Eur J Neurol. 2007 Aug;14(8):e1-2. 摘要

157. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010 Sep;17(9):1113-e88.全文  摘要

158. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015 Feb;14(2):162-73.全文  摘要

159. Dowell D, Ragan KR, Jones CM, et al. CDC clinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm Rep. 2022 Nov 4;71(3):1-95.全文  摘要

160. Gable KL, Peric S, Lutz MW, et al. A longitudinal evaluation of fatigue in chronic inflammatory demyelinating polyneuropathy. Brain Behav. 2022 Aug;12(8):e2712.全文  摘要

161. Gable KL, Attarian H, Allen JA. Fatigue in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2020 Dec;62(6):673-80. 摘要

162. Ruhland JL, Shields RK. The effects of a home exercise program on impairment and health-related quality of life in persons with chronic peripheral neuropathies. Phys Ther. 1997 Oct;77(10):1026-39. 摘要

163. ClinicalTrials.gov. A study to assess the safety and efficacy of a subcutaneous formulation of efgartigimod in adults with chronic inflammatory demyelinating polyneuropathy (CIDP, an autoimmune disorder that affects the peripheral nerves) (ADHERE). ​NCT04281472. Apr 2023 [internet publication].全文

164. ClinicalTrials.gov. ​A study to assess the efficacy, safety and tolerability of rozanolixizumab in subjects with chronic inflammatory demyelinating polyradiculoneuropathy (MyCIDPchoice). NCT03861481. May 2022 [internet publication].全文

165. Briani C, Visentin A. Therapeutic monoclonal antibody therapies in chronic autoimmune demyelinating neuropathies. Neurotherapeutics. 2022 Apr;19(3):874-84.全文  摘要

166. Fukami Y, Iijima M, Koike H, et al. Association of serum neurofilament light chain levels with clinicopathology of chronic inflammatory demyelinating polyneuropathy, including NF155 reactive patients. J Neurol. 2021 Oct;268(10):3835-44. 摘要

167. Hayashi T, Nukui T, Piao JL, et al. Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy. Brain Behav. 2021 May;11(5):e02084.全文  摘要

168. van Lieverloo GGA, Wieske L, Verhamme C, et al. Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst. 2019 Jun;24(2):187-94. 摘要

169. Simmons Z, Albers JW, Bromberg MB, et al. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain. 1995 Apr;118 (Pt 2):359-68. 摘要

170. Sghirlanzoni A, Solari A, Ciano C, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci. 2000 Feb;21(1):31-7. 摘要

171. Tackenberg B, Lünemann JD, Steinbrecher A, et al. Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology. 2007 May 8;68(19):1622-9. 摘要

172. Pedersen K, Pandolfo M, Mavroudakis N. Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment. Acta Neurol Belg. 2007 Mar;107(1):14-7. 摘要

173. Walk D, Li LY, Parry GJ, et al. Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg. Neurology. 2004 Jan 13;62(1):155-6. 摘要

174. Chin RL, Deng C, Bril V, et al. Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: comparison of patients with and without subsequent relapse. Muscle Nerve. 2015 Oct;52(4):498-502. 摘要